Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Name
Nathan Hanan
Title
Director, Clinical Pharmacology Modeling & Simulation at GSK
Bio
Nathan Hanan, PharmD, is Director of Clinical Pharmacology Modeling and Simulation at GSK, where he leads clinical pharmacology strategies and applies model-informed approaches to advance programs in neuroscience, infectious diseases, and hepatology. With over a decade of experience in drug development across industry, academia, and non-profit settings, he specializes in the integration of diverse data sources to create robust analysis subsets, enabling models that elucidate disease progression and inform strategic decisions. His recent MBMA contributions describing pegylated IFN-alpha and nucleos(t)ide cessation-induced HBsAg loss in chronic hepatitis B have helped inform Phase 3 trial strategies and regulatory interactions. Collaborating with Certara to utilize the CODEx database, Nathan will share insights from his MBMA work at Certara’s webinar to highlight advancements in therapeutic development at GSK.
